Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,258.26
-44.89 (-3.44%)
At close: Oct 22, 2026
EGX:AXPH Financials Overview
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 3,183 | 3,183 | 2,762 | 1,768 | 1,484 | 1,100 |
Revenue Growth | 15.24% | 15.24% | 56.20% | 19.12% | 34.94% | -0.38% |
Gross Profit Gross Profit Growth | 814.08 | 814.08 | 670.19 | 395.18 | 260.89 | 223.24 |
Operating Income Operating Income Growth | 672.5 | 672.5 | 504.7 | 267.49 | 154.92 | 134.54 |
Net Income Net Income Growth | 524.8 | 524.8 | 391.17 | 216.68 | 126.43 | 117.42 |
Earnings Per Share EPS Growth | 92.92 | 92.92 | 72.85 | 43.34 | 25.29 | 23.48 |
EPS Growth | 27.55% | 27.55% | 68.10% | 71.39% | 7.67% | 0.36% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 397.14 | 397.14 | 285.8 | 150.04 | 90.51 | 153.75 |
Total Debt Total Debt Growth | 9.74 | 9.74 | 4.08 | 0.81 | 12.03 | 9.11 |
Net Cash (Debt) Net Cash Growth | 387.4 | 387.4 | 281.72 | 149.22 | 78.48 | 144.63 |
Net Cash Growth | 37.51% | 37.51% | 88.79% | 90.14% | -45.74% | 187.27% |
Net Cash Per Share Net Cash Per Share Growth | 68.59 | 68.59 | 52.47 | 29.84 | 15.70 | 28.93 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 521.71 | 521.71 | 335.99 | 189.62 | 91.34 | 192.75 |
Capital Expenditures CapEx Growth | -89.26 | -89.26 | -29.72 | -62.22 | -84.25 | -31.85 |
Free Cash Flow Free Cash Flow Growth | 432.45 | 432.45 | 306.27 | 127.41 | 7.09 | 160.9 |
Free Cash Flow Growth | 41.20% | 41.20% | 140.39% | 1696.05% | -95.59% | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 25.58% | 25.58% | 24.27% | 22.35% | 17.58% | 20.29% |
Operating Margin | 21.13% | 21.13% | 18.27% | 15.13% | 10.44% | 12.23% |
Pretax Margin | 21.40% | 21.40% | 18.43% | 15.95% | 11.11% | 13.05% |
Profit Margin | 16.49% | 16.49% | 14.16% | 12.26% | 8.52% | 10.67% |
FCF Margin | 13.59% | 13.59% | 11.09% | 7.21% | 0.48% | 14.63% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Dividend Per Share Dividend Per Share Growth | 63.000 | 63.000 | 62.950 | 30.000 | 13.000 |
Dividend Per Share Growth | 109.83% | 0.08% | 109.83% | 130.77% | - |
Dividend Yield | 5.01% | 5.63% | 14.13% | 14.24% | 9.41% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 13.54 | 10.66 | 5.70 | 4.86 | 5.47 | 4.51 |
Forward PE | - | 4.57 | 4.57 | 4.57 | 4.57 | 4.57 |
P/FCF Ratio | 14.55 | 12.94 | 7.28 | 8.27 | 97.40 | 3.29 |
PS Ratio | 1.98 | 1.76 | 0.81 | 0.60 | 0.47 | 0.48 |